Rostec Press Office
Moscow health authorities announced the launch of the second phase of testing for the “Covid-globulin” drug to treat the Corona virus.
The press office of the Health Care Administration in Moscow said today, Tuesday, that the trials will include 6 hospitals in Moscow that treat people with Coronavirus, while the second phase of the trials is scheduled to take two or three months.
It is reported that “Covid-globulin” was formulated on the basis of the blood plasma of people with Coronavirus, which contains antibodies to the virus.
It is noteworthy that the medicine reduces the severity of the symptoms of the disease and helps in enhancing immunity until cure.